ARTICLE | Company News
Keryx sales and marketing update
January 12, 2015 8:00 AM UTC
Keryx launched Auryxia ferric citrate tablets in the U.S. to control serum phosphorus levels in patients with chronic kidney disease (CKD) on dialysis. The oral ferric iron-based phosphate binder has...